G1 Therapeutics

G1 Therapeutics
Company type	Public
Traded as	Nasdaq: GTHX
Industry	Pharmaceuticals
Founded	2008; 16 years ago
Founders	Norman Sharpless; Kwok-Kin Wong;
Headquarters	North Carolina, United States
Key people	Jack Bailey (CEO); Terry Murdock (COO); John Umstead V (CFO); Raj Malik, M.D. (CMO); Andrew Perry (CCO); Mark Avagliano (CBO);
Products	Cosela
Owner	Pharmacosmos; (2024–present);
Number of employees	170 (Dec. 2022)
Website	g1therapeutics.com

G1 Therapeutics, Inc. is an American biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company specializes in developing and commercializing small molecule therapeutics for the treatment of patients with cancer.^[1]

^ Kaplan S (12 March 2019). "National Cancer Chief, Ned Sharpless, Named F.D.A.'s Acting Commissioner (Published 2019)". The New York Times. ISSN 0362-4331. Retrieved 11 December 2020.

[1] Kaplan S (12 March 2019). "National Cancer Chief, Ned Sharpless, Named F.D.A.'s Acting Commissioner (Published 2019)". The New York Times. ISSN 0362-4331. Retrieved 11 December 2020.

[1]